Abstract
Neosporosis is an economically important disease of dairy cattle caused by the protozoan Neospora caninum. Diagnostic tests for neosporosis are complicated by the potential for cross-reaction of antibodies to antigens that are similar between N. caninum and closely related parasites Toxoplasma gondii and Sarcocystis cruzi. To provide a sensitive and specific assay for detecting antibodies to N. caninum in the serum of infected animals, we have investigated a recombinant form of the antigen known as Ncp29 (rNcp29), which is a major surface protein of the parasite. Ncp29 is encoded by a gene that is homologous to the SAG1 gene previously characterized from T. gondii. An enzyme-linked immunosorbent assay (ELISA) was used to screen animals for the presence of serum antibodies specific to rNcp29. The rNcp29 ELISA readily distinguished between cattle known to be infected with N. caninum (optical density [OD] > 1.2 at 1:500 or greater dilution) and negative controls (OD < 0.5 at 1:500). Additionally, sera from animals that were infected with T. gondii or S. cruzi were negative. The rNcp29 ELISA developed here provides a specific and sensitive assay for detecting neosporosis in cattle.
Neospora caninum is a coccidian parasite that causes abortions and neonatal morbidity and mortality in cattle, sheep, goats, deer, and horses (15). Neosporosis is an economically important disease in cattle, where it causes abortion and paralysis of newborn animals. Outbreaks of neosporosis are sporadic but have been reported in the United States, Sweden, The Netherlands, the United Kingdom, South Africa, Japan, Australia, and New Zealand (16). Neosporosis is also an important cause of paralysis in dogs (12), and it has been recently discovered that the dog is capable of oral-fecal transmission of this parasite (33). Herbivorous mammals, including dairy cows, presumably become infected by ingesting the resistant oocysts (a spore-like stage), which are passed in dog feces and which contaminate feed, range, and water sources. Additionally, vertical transmission from mother to offspring is probably responsible for much of the infection burden in animals (16). Thus, control of neosporosis will ultimately rely on detection of infections in both the dog and the various intermediate hosts such as cattle.
N. caninum is closely related to Toxoplasma gondii based on ribosomal small-subunit RNA sequences (31), and they have significant morphological, life cycle, and molecular similarities. Due to the close similarity between these two organisms, serological diagnosis is complicated by the potential for false-positive results due to antigenic cross-reactivity (6, 20). Their close similarity is evident from the many homologous T. gondii genes that also exist in N. caninum. For example, we have recently characterized homologues of the genes encoding nucleoside hydrolase NTPases (2) and a member of a conserved family of adhesins, known as MIC2, which is involved in recognition of the host cell (30). In previous studies, we and others have shown that the major surface antigens of N. caninum, known as Ncp29 (also called Nc-p36) and Ncp35 (also called Nc-p43), belong to a family of antigens that were first identified in T. gondii and that are characterized by the conservation of the spacing and number of cysteine residues (18, 19, 21). These surface antigens are collectively known as SAGs, and Ncp29 is a homologue of T. gondii SAG1, while Ncp35 is a homologue of T. gondii SRS2 (21).
Detection of N. caninum infection in animals is most easily determined by the presence of antibodies in the serum. Diagnostic assays based on the immunofluorescent antibody test (IFAT) and using whole parasite antigens from cultures adapted for growth in vitro have been developed for N. caninum (3, 9, 13). While an extremely important development for establishing the etiology of abortion in cattle due to protozoans, this assay requires experienced and trained personnel and is subjective in nature, making results from different laboratories difficult to compare. Due to the reliance on whole antigens, the IFAT also increases the likelihood of cross-reaction with antibodies to conserved antigens that may be found in other related parasites. One example of this is that polyclonal sera from animals immunized or infected with N. caninum often recognize cross-reacting proteins in lysates of T. gondii (6, 20). While these cross-reacting bands are typically weaker than the homologous antigen preparation and thus can be factored out by using appropriate dilutions, cross-reactions still complicate the development of standardized diagnostic tests. Consequently, there is a need for development of standardized diagnostic test that offers reliable, sensitive, and specific detection based on defined Neospora-specific molecules.
Despite a high degree of molecular similarity between T. gondii and N. caninum, we have observed that a majority of the monoclonal antibodies to T. gondii that are generated do not cross-react to N. caninum (23) and that, correspondingly, monoclonal antibodies to cell surface proteins Ncp29 and Ncp35 do not cross-react to T. gondii (21). Surface protein Ncp35 has recently been purified in a native form from the parasite and used in an enzyme-linked immunosorbent assay (ELISA) to detect antibodies in infected cattle (35). However, the use of native antigens requires the propagation of the parasite in mammalian cell culture, an expensive and time-consuming process. Recombinant antigens have the added benefit that they are easily produced in large quantities and can be readily standardized for diagnostic assays. This led us to explore the possibility of using recombinant antigens to develop a species-specific diagnostic assay for neosporosis.
We have designed an ELISA that utilizes recombinant Ncp29 (rNcp29), an immunodominant surface antigen of N. caninum tachyzoites. This assay provides a sensitive and specific detection of antibodies in sera of infected animals and is not complicated by cross-reactions to antisera against related parasites such as T. gondii.
MATERIALS AND METHODS
Recombinant-protein production.
The open reading frame of the gene encoding Ncp29 (GenBank accession no. AF132217) was amplified with Klentaq-LA polymerase (Clontech) from genomic DNA of the Nc-1 strain of N. caninum. The sequence of the forward primer was 5′GATCCATATGTCAGAAAAATCACCTCTAC3′. The sequence of the reverse primer was 5′GATCCTCGAGCGCTATCGAGCCTACG3′. The PCR-amplified fragment was ligated into an NdeI- and XhoI-digested pET-22b expression vector (Novagen) by using NdeI and XhoI restriction sites that were incorporated into the amplification primers. The resulting recombinant protein lacks the predicted 30-amino-acid signal peptide at the N terminus and the last 4 amino acids of the carboxyl terminus of the native protein and contains a C-terminal histidine tag. Plasmid prNcp29 was transformed into Escherichia coli, BL21, and a clone that expressed high levels of rNcp29 was selected for use. Following induction with IPTG, rNcp29 was extracted from inclusion bodies with 6 M urea, and the protein was purified by nickel column chromatography according to the manufacturer's protocol (Novagen). The purified protein was concentrated with Centricon-10 columns (Amicon), and the protein concentration was determined by a colorimetric protein assay (Pierce) prior to storage at −80C until use.
SDS-PAGE and Western blotting.
Tachyzoites of the Nc-1 strain of N. caninum were propagated in human fibroblasts and purified as described previously (21). Parasite cell pellets and lysates of bacteria expressing recombinant Ncp29 were resuspended in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and separated on 10% acrylamide gels (25). Proteins were transferred to nitrocellulose by semidry electrophoresis in Tris-glycine, pH 8.3, and Western blotted by using horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch Labs) and chemiluminescence (Pierce) as described previously (21). Primary antisera consisted of sera from mice that were chronically infected with N. caninum and previously described monoclonal antibody 6C11, which reacts to Ncp29 (21).
ELISA.
Purified rNcp29 was diluted to 10 μg/ml in phosphate-buffered saline (PBS), 100 μl of the mixture was added to each well in high-binding-capacity ELISA plates (Corning), and wells were incubated for 1 h at 37°C or overnight at 4°C. The plates were rinsed three times with PBS containing 0.05% Tween 20 and blocked for 1 h with PBS containing 0.05%Tween 20 and 1% gamma globulin-free bovine serum albumin (BSA; Sigma, St. Louis, Mo.). Antisera were diluted in PBS containing 0.05% Tween 20 and 0.1% BSA, 100 μl of the mixture was added to each of duplicate wells of the ELISA plate, and the wells were incubated for 2 h at room temperature (RT). The wells were rinsed three times with PBS containing 0.05% Tween 20 and incubated for 2 h at RT with 100 μl of protein G-horseradish peroxidase conjugate (Pierce) diluted to 1:2,500 in PBS containing 0.05% Tween 20 and 0.1% BSA. Finally the plate was rinsed four times with PBS containing 0.05% Tween 20. Chromogenic substrate o-phenylenediamine dihydrochloride (Sigma) was dissolved in 0.05 M phosphate-citrate buffer to a concentration of 0.4 mg/ml, and 200 μl of substrate was added to each well. After a 10-min incubation, the reaction was stopped with 50 μl of 2 M H2SO4, and the A490 was measured in an ELISA plate reader. Samples were performed in duplicate, and mean values are reported.
Bovine sera.
Samples were obtained from three uninfected cows and again following experimental infection with tachyzoites of the BPA-1 isolate of N. caninum (1, 8). Serum samples were also obtained from 10 known positive animals and 10 known negative animals, as determined by IFAT (9). A complete description of the sera and the clinical histories for the animals can be found in Table 1. To assess the specificity of the rNcp29 ELISA, we also obtained serum samples from bovine animals that were experimentally infected with either Sarcocystis cruzi or T. gondii (17).
TABLE 1.
Reciprocal titers of serum samples from cattle confirmed positive and negative for infection with N. caninum
| Samplea | Animal
|
Diagnosisb | Titerc by:
|
||
|---|---|---|---|---|---|
| No. | Type | IFAT | rNcp29 ELISA | ||
| N1 | 25Z | Adult | Negative | <80 | <100 |
| N2 | 66/74 | Adult | Negative | <80 | <100 |
| N3 | 369 | Adult | Negative | <80 | <100 |
| N4 | 370 | Adult | Negative | <80 | <100 |
| N5 | 405 | Adult | Negative | <80 | <100 |
| N6 | 2290 | Adult | Negative | <80 | <100 |
| N7 | 354 | Adult | Negative | <80 | <100 |
| N8 | 374 | Adult | Negative | <80 | <100 |
| N9 | 398 | Adult | Negative | <80 | <100 |
| N10 | 364 | Adult | Negative | <80 | <100 |
| P1 | CS1 | Calfd | Positive | 20,480 | 16,000 |
| P2 | CS2 | Calf | Positive | 20,480 | 32,000 |
| P3 | 1088 | Adult | Positive | 20,480 | 32,000 |
| P4 | 2744 | Adult | Positive | 1,280 | 16,000 |
| P5 | 48291 | Calf | Positive | 1,280 | 16,000 |
| P6 | 5629 | Adult | Positive | 10,240 | 32,000 |
| P7 | CS3 | Adult | Positive | 640 | 8,000 |
| P8 | 522 | Adult | Positive | 160 | 8,000 |
| P9 | 927 | Adult | Positive | 640 | 8,000 |
| P10 | 3923 | Adult | Positive | 640 | 8,000 |
| Pre1 | 412 | Adult | Preinoculation | <80 | ND |
| Post1 | 412 | Adult | Postinoculation | 10,240 | ND |
| Pre2 | 7 | Adult | Preinoculation | <80 | ND |
| Post2 | 7 | Adult | Postinoculation | 10,240 | ND |
| Pre3 | A114 | Adult | Preinoculation | <80 | ND |
| Post3 | A114 | Adult | Postinoculation | 10,240 | ND |
Pre, sample from clinically normal cow taken before experimental infection; Post, sample from the same cow taken after infection (1, 8).
Positive, positive immunoperoxidase result and detectable parasite clusters, with free tachyzoites detected in tissues of infected or aborted offspring; negative, healthy, normal control.
Reciprocal titer, where the OD was twofold greater than that for the pooled negative sera. ND, not done.
Calves were infected congenitally and were sampled postcolostrum.
RESULTS AND DISCUSSION
To assess the immunoreactivity of rNcp29, the recombinant protein was expressed in E. coli as a His-tagged fusion protein and purified by nickel chromatography. rNcp29 was readily recognized in Western blots by antisera from Neospora-infected mice and by murine monoclonal antibody 6C11, which had been previously selected for its reactivity to native Ncp29 (21) (Fig. 1). The preservation of the antigenicity of rNcp29 contrasts with previous findings that homologous protein SAG1 in T. gondii is misfolded when expressed in E. coli such that the antigen is not readily recognized by antibodies to the native protein (7). Conformationally correct SAG1 from T. gondii has been produced in mammalian cells (24) and in Pichia pastoris (5), although these systems can lead to altered secondary modifications such as glycosylation. The observation that rNcp29 produced in E. coli is recognized by antisera to the native protein suggests that it is folded sufficiently to retain its antigenic nature. Consequently, we decided to evaluate the potential use of rNcp29 for specific detection of neosporosis by testing for antibodies to the protein in sera of Neospora-infected versus noninfected animals.
FIG. 1.
Western blot analysis of rNcp29 and N. caninum lysate (Nc-1) using monoclonal antibody 6C11, which reacts to native Ncp29, and mouse polyclonal antiserum against strain Nc-1 of N. caninum.
We used the rNcp29 ELISA to test a collection of 26 bovine sera that had been previously characterized by IFAT for anti-N. caninum antibodies (Table 1) (1, 9). These samples were obtained from pair-wise pre- and postinfection sera collected from three animals that were experimentally infected by inoculation with the BPA-1 isolate of N. caninum. Initial testing was based on serum dilutions of 1:100 to 1:1,000. While the higher dilutions still provided strong positives, the optimal signal relative to background was obtained at 1:500 (data not shown); consequently this dilution was used for all further testing. Additional samples were from 10 confirmed cases of neosporosis and 10 healthy, serologically negative cows. Several of the known positive animals had previously aborted N. caninum-positive fetuses (P3, P4, P7, P8, P9, and P10), and several were calves that were confirmed to be infected by histological examination (P1, P2, and P5) (Table 1). The rNcp29 ELISA clearly distinguished the antisera of animals that had been experimentally or naturally infected with N. caninum from antisera of the noninfected animals (Fig. 2). The optical densities at 490 nm (OD490) for the positive samples ranged from 1.5 to 2.7 at a dilution of 1:500, while the OD490 for the negative samples were all below 0.5. We considered this value of 0.5 to be the upper limit for negative titers based on a 1:500 dilution of whole serum. Serial dilution of serum samples was used to determine the end point titers, defined as the reciprocal of the dilution where the values for positive samples were still twofold above the values for pooled samples from 10 negative animals (Table 1). In general, the titers obtained by the rNcp29 ELISA and IFAT were similar; however, the rNcp29 assay was more sensitive, detecting higher titers in animals P7, P8, P9, and P10 than the IFAT. The positive cutoff for the IFAT is considered to be 1:320; therefore animal P8 would have been missed by this assay yet was clearly positive by the rNcp29 ELISA. There was no significant increase in ELISA titers for the negative animals relative to the IFAT titers.
FIG. 2.
rNcp29 ELISA results for 10 positive and 10 negative bovine sera and pre (−) and postinoculation (+) serum samples from three experimentally infected cows. Negative herd samples correspond to the N1 to N10 samples in Table 1. Positive herd samples correspond to the P1 to P10 samples in Table 1. Experimental controls correspond to the Pre1, -2, and -3 and Post1, -2, and -3 samples in Table 1.
Previous serological assays have been hampered by the potential for cross-reaction of Neospora antigens with those of closely related parasites such as T. gondii (6, 20). Therefore, an additional 23 bovine antisera from animals that had been experimentally infected with either T. gondii or S. cruzi were also tested by the rNcp29 ELISA. With the exception of a single animal that had been experimentally infected with Sarcocystis (sample S9), all of the control antisera exhibited an OD490 of <0.5, while, by comparison, the known positive animals listed in Table 1 exhibited OD490 values of >1.5 (Fig. 3). Further examination of the sample from animal S9 using a variety of assays revealed that this animal had an elevated anti-Neospora titer, thus indicating that it had previously been naturally infected with N. caninum. (17).
FIG. 3.
rNcp29 ELISA results for bovine antisera from animals that were naturally infected with N. caninum or experimentally infected with T. gondii or Sarcocystis spp. Samples P1 to P10 correspond to those listed in Table 1. ∗, previously N. caninum-infected animal (17).
Despite the similarity with related gene product SAG1, which occurs in T. gondii, we did not detect antigenic cross-reaction between N. caninum and T. gondii by using rNcp29. Animals infected with N. caninum reacted strongly to Ncp29 while those infected with T. gondii showed negative ELISA titers. Proteins Ncp29 and SAG1 (also known as p30) from T. gondii have approximately 50% identity at the amino acid level, and both contain 12 cysteine residues that are predicted to be involved in the conformational folding of the protein, a property that is likely important for the highly antigenic nature of SAG1 (5, 7, 24). Following infection with T. gondii, antibodies to SAG1 appear very early and include immunoglobulin M (IgM) and IgA, as well as IgG classes (10, 34), making this antigen ideally suited for detection of acute infection. Due to its unique antigenicity, surface location, and abundant expression in N. caninum, Ncp29 will likely prove to be an excellent antigen for detection of early infection during outbreaks of neosporosis.
Isolation of recombinant parasite antigens that react to sera from N. caninum-infected animals has previously been used to identify several other candidate antigens for serodiagnosis. Two such clones, initially called Nc4.1 and Nc14.1, have been used in an ELISA to distinguish between infected and noninfected cows by detecting antibodies in the serum (26). Completion of the sequences originally identified by Nc14.1 and Nc4.1 revealed they are homologous to products of the GRA6 and GRA7 genes, respectively, of T. gondii, which encode proteins found in secretory dense granules (22, 26, 27). In separate studies, clones N54 and N57 were isolated based on screening a recombinant library with serum from a naturally infected cow (29). Antigen N54 corresponds to clone Nc4.1 described above, while N57 is a portion of a subtilisin-like protease (28). These were utilized as recombinant proteins for development of an ELISA for screening herd serum based on the presence of specific antibodies to N. caninum (29). The recombinant antigens did not show cross-reactivity to T. gondii and performed significantly better in the ELISA than whole tachyzoite antigens. However, in both cases, a wide range of positive values are observed in infected animals, and hence the difference between negative and positive sera is often slight, a problem also encountered by using the Nc41 and Nc14.1 antigens described above (leading to overlapping values or differences of less than 0.1 OD unit). In contrast, the rNcp29 ELISA described here detected a large difference between positive (OD ≥ 1.2) and negative (OD ≤ 0.5) sera. Whether this is due to a higher degree of sensitivity remains to be established by further testing of additional samples, for example, from field surveys of naturally infected herds. Additionally, it will be important to evaluate the assay on longitudinal samples from animals pre- and postabortion to determine the positive predictive value of specific titers.
Although we have only evaluated the rNcp29 ELISA with bovine samples, the assay may also be useful for diagnosis of neosporosis in dogs. Canids are a definitive host for N. caninum (33), and detection of infections in dogs could be of practical value in two ways. First, adequate control of neosporosis on cattle farms will ultimately depend on disrupting transmission. Good management practices to prevent infection will be aided by determining which animals are infected. Secondly, neosporosis is a cause of neurological disease in dogs (11, 14, 16). Early detection of these infections, combined with adequate treatment, could prevent recurrent episodes of congenital infection and paralysis that have been known to occur in dogs (11, 12).
We have recently reported that the gene encoding the p29 antigen is entirely conserved among a variety of isolates of N. caninum from bovine and canine hosts from North America and Europe (GenBank accession no. AF141960, AF141961, AF141962, and AF141963) (32). Such a high degree of conservation indicates that the rNcp29 ELISA will be widely applicable to a range of different isolates that could potentially infect different hosts species. Experimental infections of nonhuman primates indicate a capacity of N. caninum to cause congenital infection and disease in rhesus monkeys (4). While N. caninum is generally not considered an agent of human infection, exposure of humans by consumption of animal tissues and close contact with infected animals may pose a risk of infection. Indeed, a recent survey indicated positive serological titers in several humans suggesting that additional testing is warranted (36). The interest in emerging pathogens, particularly those which may be food borne, supports such screening, and it is likely that the rNcp29 ELISA described here will provide a sensitive assay to conduct such serological surveys in the future.
Acknowledgments
We thank Olivia Giddings for expert technical assistance in maintaining cell cultures.
This study was supported in part by USDA NRI grants 97-35204-4770 and 99-35204-8615.
REFERENCES
- 1.Andrianarivo, A. G., B. C. Barr, M. L. Anderson, J. D. Rowe, A. E. Packman, K. W. Sverlow, and P. A. Conrad. 2001. Immune responses in pregnant cattle and bovine fetuses following experimental infection with Neospora caninum. Parasitol. Res. 87:817-825. [DOI] [PubMed] [Google Scholar]
- 2.Asai, T., D. K. Howe, K. Nakajima, T. Nozaki, T. Takeuchi, and L. D. Sibley. 1998. Neospora caninum: tachyzoites express a potent type-I nucleoside triphosphate hydrolase, but lack nucleoside diphosphate hydrolase activity. Exp. Parasitol. 90:277-285. [DOI] [PubMed] [Google Scholar]
- 3.Barr, B. C., M. L. Anderson, K. W. Sverlow, and P. A. Conrad. 1995. Diagnosis of bovine fetal Neospora infection with an indirect fluorescent antibody test. Vet. Rec. 137:611-613. [PubMed] [Google Scholar]
- 4.Barr, B. C., P. A. Conrad, K. W. Sverlow, A. F. Tarantal, and A. G. Hendrickx. 1994. Experimental fetal and transplacental Neospora infection in the nonhuman primate. Lab. Investig. 71:236-242. [PubMed] [Google Scholar]
- 5.Biemans, R., D. Grégoire, M. Haumont, A. Bosseloir, L. Garcia, A. Jacquet, C. Dubeaux, and A. Bollen. 1998. The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation. J. Biotechnol. 66:137-146. [DOI] [PubMed] [Google Scholar]
- 6.Bjerkas, I., M. C. Jenkins, and J. P. Dubey. 1994. Identification and characterization of Neospora caninum tachyzoite antigens useful for diagnosis of neosporosis. Clin. Diagn. Lab. Immunol. 1:214-221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Burg, J. L., D. Perlman, L. H. Kasper, P. L. Ware, and J. C. Boothroyd. 1988. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol. 141:3584-3591. [PubMed] [Google Scholar]
- 8.Conrad, P. A., B. C. Barr, K. W. Sverlow, M. Anderson, B. Daft, H. Kinde, J. P. Dubey, L. Munson, and A. Ardans. 1993. In vitro isolation and characterization of a Neospora sp. from aborted bovine fetuses. Parasitology 106:239-249. [DOI] [PubMed] [Google Scholar]
- 9.Conrad, P. A., K. Sverlow, M. Anderson, J. Rowe, R. BonDurant, G. Tuter, R. Breitmeyer, C. Palmer, M. Thurmond, A. Ardans, J. P. Dubey, G. Duhamel, and B. Barr. 1993. Detection of serum antibody responses in cattle with natural or experimental Neospora infections. J. Vet. Diagn. Investig. 5:572-578. [DOI] [PubMed] [Google Scholar]
- 10.Decoster, A., A. Caron, F. Darcy, and A. Capron. 1988. IgA antibodies against p30 as markers of congenital and acute toxoplasmosis. Lancet ii:1104-1106. [DOI] [PubMed]
- 11.Dubey, J. P., J. L. Carpenter, C. A. Speer, M. J. Topper, and A. Uggla. 1988. Newly recognized fatal protozoan disease of dogs. J. Am. Vet. Med. Assoc. 192:1269-1285. [PubMed] [Google Scholar]
- 12.Dubey, J. P., K. R. Dorough, M. C. Jenkins, S. Liddell, C. A. Speer, O. C. H. Kwok, and S. K. Shen. 1998. Canine neosporosis: clinical signs, diagnosis, treatment and isolation of Neospora caninum in mice and cell structure. Int. J. Parasitol. 28:1293-1304. [DOI] [PubMed] [Google Scholar]
- 13.Dubey, J. P., M. C. Jenkins, D. S. Adams, M. M. McAllister, R. Anderson-Sprecher, T. V. Baszler, O. C. H. Kwok, N. C. Lally, C. Bjorkman, and A. Uggla. 1997. Antibody responses of cows during an outbreak of neosporosis evaluated by indirect fluorescent antibody test and different enzyme-linked immunosorbent assays. J. Parasitol. 83:1063-1069. [PubMed] [Google Scholar]
- 14.Dubey, J. P., A. Koestner, and R. C. Piper. 1990. Repeated transplacental transmission of Neospora caninum in dogs. J. Am. Vet. Med. Assoc. 197:857-860. [PubMed] [Google Scholar]
- 15.Dubey, J. P., and D. S. Lindsay. 1993. Neosporosis. Parasitol. Today 9:452-458. [DOI] [PubMed] [Google Scholar]
- 16.Dubey, J. P., and D. S. Lindsay. 1996. A review of Neospora caninum and neosporosis. Vet. Parasitol. 67:1-59. [DOI] [PubMed] [Google Scholar]
- 17.Dubey, J. P., D. S. Lindsay, D. S. Adams, J. M. Gay, T. V. Baszler, B. L. Blagburn, and P. Thulliez. 1996. Serologic responses of cattle and other animals infected with Neospora caninum. Am. J. Vet. Res. 57:329-336. [PubMed] [Google Scholar]
- 18.Hemphill, A., R. Felleisen, B. Connoly, B. Gottstein, B. Hentrich, and N. Muller. 1997. Characterization of a cDNA-clone encoding Nc-p43, a major Neospora caninum tachyzoite surface protein. Parasitology 115:581-590. [DOI] [PubMed] [Google Scholar]
- 19.Hemphill, A., N. Fuchs, S. Sonda, B. Gottstein, and B. Hentrich. 1997. Identification and partial characterization of a 36 kDa surface protein on Neospora caninum tachyzoites. Parasitology 115:371-380. [DOI] [PubMed] [Google Scholar]
- 20.Hemphill, A., and B. Gottstein. 1996. Identification of a major surface protein on Neospora caninum tachyzoites. Parasitol. Res. 82:497-504. [DOI] [PubMed] [Google Scholar]
- 21.Howe, D. K., A. C. Crawford, D. Lindsay, and L. D. Sibley. 1998. The p29 and p35 immunodominant antigens of Neospora caninum tachyzoites are homologous to the family of surface antigens of Toxoplasma gondii. Infect. Immun. 66:5322-5328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Howe, D. K., and L. D. Sibley. 1999. Comparison of the major antigens of Neospora caninum and Toxoplasma gondii. Intl. J. Pasrasitol. 29:1489-1496. [DOI] [PubMed] [Google Scholar]
- 23.Howe, D. K., and L. D. Sibley. 1997. Development of molecular genetics for Neospora caninum: a complementary system to Toxoplasma gondii. Methods 13:123-133. [DOI] [PubMed] [Google Scholar]
- 24.Kim, K., R. Bulow, J. Kampmeier, and J. C. Boothroyd. 1994. Conformationally appropriate expression of the Toxoplasma antigen SAG1 (p30) in CHO cells. Infect. Immun. 62:203-209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227:680-685. [DOI] [PubMed] [Google Scholar]
- 26.Lally, N., M. Jenkins, S. Liddell, and J. P. Dubey. 1997. A dense granule protein (NCDG1) gene from Neospora caninum. Mol. Biochem. Parasitol. 87:239-243. [DOI] [PubMed] [Google Scholar]
- 27.Liddell, S., N. C. Lally, M. C. Jenkins, and J. P. Dubey. 1998. Isolation of the cDNA encoding a dense granule associated antigen (NCDG2) of Neospora caninum. Mol. Biochem. Parasitol. 93:153-158. [DOI] [PubMed] [Google Scholar]
- 28.Louie, K., and P. A. Conrad. 1999. Characterization of a cDNA encoding a subtilisin-like serine protease (NC-p65) of Neospora caninum. Mol. Biochem. Parasitol. 103:211-223. [DOI] [PubMed] [Google Scholar]
- 29.Louie, K., K. W. Sverlow, B. C. Barr, M. L. Anderson, and P. A. Conrad. 1997. Cloning and characterization of two recombinant Neospora protein fragments and their use in serodiagnosis of bovine neosporosis. Clin. Diagn. Lab. Immunol. 4:692-699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lovett, J. L., D. K. Howe, and L. D. Sibley. 2000. Molecular characterization of a thrombospondin-related anonymous protein homologue in Neospora caninum. Mol. Biochem. Parasitol. 107:33-43. [DOI] [PubMed] [Google Scholar]
- 31.Marsh, A. E., B. C. Barr, K. Sverlow, M. Ho, J. P. Dubey, and P. A. Conrad. 1995. Sequence analysis and comparison of ribosomal DNA from bovine Neospora to similar coccidial parasites. J. Parasitol. 81:530-535. [PubMed] [Google Scholar]
- 32.Marsh, A. E., D. K. Howe, G. Wang, B. C. Barr, N. Cannon, and P. A. Conrad. 1999. Differentiation of Neospora hughesi from Neospora caninum based on their immunodominant surface antigens, SAG1 and SRS2. Int. J. Parasitol. 29:1575-1582. [DOI] [PubMed] [Google Scholar]
- 33.McAllister, M. M., J. P. Dubey, D. S. Lindsay, W. R. Jolley, R. A. Wills, and A. M. McGuire. 1998. Dogs are definitive hosts of Neospora caninum. Int. J. Parasitol. 28:1473-1478. [PubMed] [Google Scholar]
- 34.Santoro, F., D. Afchain, R. Pierce, J. Y. Cesbron, G. Ovalaque, and A. Capron. 1985. Serodiagnosis of Toxoplasma infection using a purified parasite protein (p30). Clin. Exp. Immunol. 62:262-269. [PMC free article] [PubMed] [Google Scholar]
- 35.Schares, G., M. Rauser, P. Sondgen, P. Rehberg, A. Bårwald, J. P. Dubey, R. Edelhofer, and F. J. Conraths. 2000. Use of purified tachyzoite surface antigen p38 in an ELISA to diagnose bovine neosporosis. Int. J. Parasitol. 30:1123-1130. [DOI] [PubMed] [Google Scholar]
- 36.Tranas, J., R. A. Heinzen, L. M. Weiss, and M. M. McAllister. 1999. Serological evidence of human infection with the protozoan Neospora caninum. Clin. Diagn. Lab. Immunol. 6:765-767. [DOI] [PMC free article] [PubMed] [Google Scholar]



